Results 221 to 230 of about 357,788 (307)
An Unusual Finding on Kidney Biopsy in a Patient with Mild Kidney Dysfunction. [PDF]
Xu Q, Fang Y, Zhang H.
europepmc +1 more source
ABSTRACT Background The current literature summarizes the trends in the surgical management of stress urinary incontinence (SUI) and not the general trends of management for all UI types in the US. Additionally, recent evidence on racial and ethnic disparities in UI related surgical utilization is limited. Objective To describe the currently prescribed
Rawan O. Almadfaa +5 more
wiley +1 more source
Roxadustat for Erythropoiesis-Stimulating Agent Hyporesponsive Anemia in Hemodialysis: Multicenter Retrospective Analysis. [PDF]
Ozturk I +11 more
europepmc +1 more source
ABSTRACT Aims Urinary incontinence (UI) is a prevalent condition among adults and imposes a substantial societal burden, yet its association with all‐cause mortality remains uncertain. This study systematically reviewed and quantified the association between UI and mortality risk.
Yanyan Zhou +6 more
wiley +1 more source
The Weight of Disease, the Loss Within: Rethinking Frailty Assessment in ADPKD. [PDF]
Paolisi M +8 more
europepmc +1 more source
Symptom Relief and Practice Setting Variation in Bulkamid Injections for Stress Urinary Incontinence
ABSTRACT Introduction Bulkamid™ transurethral injection is a minimally invasive treatment for stress urinary incontinence (SUI) and mixed urinary incontinence (MUI). While effective, predictors of repeat injection, progression to sling, and the influence of anesthesia type on treatment efficacy remain incompletely defined.
Christina Sze +6 more
wiley +1 more source
Correction: Short-term outcome and prognostic factors in acute fulminant myocarditis with acute kidney injury patients. [PDF]
Frontiers Production Office.
europepmc +1 more source
ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang +2 more
wiley +1 more source

